Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit

E-ISSN： 1873-5592|12|10|1498-1512

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.10, 2011-09, pp. : 1498-1512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones in the treatment of Type 2 diabetes

By Greenberg Andrew S Pittas Anastassios G

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 529-540

Informa Healthcare

Access to resources Recommend Favorite

Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes

By Schwartz Ann V Sellmeyer Deborah E

Expert Opinion on Drug Safety, Vol. 7, Iss. 1, 2008-01 ,pp. : 69-78

Informa Healthcare

Access to resources Recommend Favorite

Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence

By Diamant M. Heine R.J.

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1373-1405

Adis International

Access to resources Recommend Favorite

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan

By Hsiao Fei-Yuan Huang Weng-Foung

Drug Safety, Vol. 32, Iss. 8, 2009-08 ,pp. : 675-690

Adis International

Access to resources Recommend Favorite